3SBio submits application for Phase I scientific trial of NuPIAO to the Chinese SFDA 3SBio Inc.

3SBio submits application for Phase I scientific trial of NuPIAO to the Chinese SFDA 3SBio Inc. , a respected biotechnology company centered on researching, developing, manufacturing and marketing biopharmaceutical products mainly in China, today announced that it provides submitted its software for a Phase I clinical trial for NuPIAO to the Chinese Condition Food and Drug Administration http://edmdrx.com/ . NuPIAO is definitely a highly glycosylated ESA with extended half-life and elevated biologic activity. Pre-clinical results showed a promising pharmacokinetic profile which would allow a once weekly injection routine of NuPIAO in human beings.

The addition of Hybrivet Systems provides 3M immediate usage of the potentially large marketplace for tests paints for lead in old houses and commercial structures to meet up new Environmental Protection Agency lead-safe work procedures rules. ‘The LeadCheck items complement and build on our paint preparation, protection and tape businesses and broaden our item offerings in the color aisle,’ stated Jack Truong, vice president and general supervisor, 3M Construction and DO-IT-YOURSELF Markets Division. Hybrivet Systems is situated in Natick, Mass.